4 Reasons Obamacare is Good For Medtech (slideshow)

Posted in Medical Device Business by Arundhati Parmar on August 28, 2013


With all the bad-blood regarding the medical device tax, it may be hard to imagine that there are actually aspects of the Affordable Care Act (aka Obamacare) that actually bode well for medical technology firms.

Here is a slideshow of four areas of opportunity for medtech firms under Obamacare. They are based on expert opinion from Patrick Hurd, attorney at LeClairRyan; Frederick Brown, healthcare practice managing director for Ducker Worldwide; and a report from Danielle Antalffy, research analyst at healthcare investment bank Leerink Swann.

Demand for Elective Procedures Will Likely Rise

  • As more people get insured under the Affordable Care Act, they might choose to undergo elective procedures that may have been too expensive before.


  • These would include hip and knee replacements, plastic surgery, and lap band procedures to tackle obesity, among many other elective procedures.


  • Companies that may stand to benefit are orthopedics  firms Stryker and Johnson & Johnson, as well as obesity treatment companies like Allergan, not to mention start-ups in the space looking to capture marketshare from the big companies.  




[Photo Credit:]

-- By Arundhati Parmar, Senior Editor, MD+DI 

Learn more about how Obamacare is affecting next-generation medical technologies in a conference session at MEDevice San Diego, on September 26, 2013.


Printer-friendly version
No votes yet

Login to post comments